Stock RECKITTBEN RECKITT BENCKISER (BANGLADESH) PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Reckitt Benckiser (Bangladesh) PLC

Equities

RECKITTBEN

BD0460RECKT2

Pharmaceuticals

End-of-day quote Dhaka S.E.
Other stock markets
 23:00:00 08/05/2024 BST 		5-day change 1st Jan Change
4,298 BDT -0.62% Intraday chart for Reckitt Benckiser (Bangladesh) PLC -1.77% -9.73%
04-29 Reckitt Benckiser PLC Reports Earnings Results for the First Quarter Ended March 30, 2024 CI
04-23 Reckitt Benckiser PLC Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 10,157 15,088 19,121 27,074 22,494 22,494
Enterprise Value (EV) 1 9,207 13,776 17,500 25,608 20,703 19,776
P/E ratio 30.6 x 24.4 x 25.9 x 33.5 x 34.1 x 27.4 x
Yield 3.26% 3.91% 3.46% 2.88% 2.06% 1.16%
Capitalization / Revenue 2.61 x 3.66 x 3.58 x 5.48 x 4.53 x 4.26 x
EV / Revenue 2.37 x 3.34 x 3.28 x 5.18 x 4.17 x 3.74 x
EV / EBITDA 16.1 x 14.6 x 15 x 21.3 x 20.2 x 15.9 x
EV / FCF 20.5 x 22.5 x 22.5 x 51.4 x 18.9 x 15.6 x
FCF Yield 4.88% 4.44% 4.44% 1.95% 5.3% 6.42%
Price to Book 26.3 x 22.4 x 23.7 x 28.6 x 26.9 x 18.8 x
Nbr of stocks (in thousands) 4,725 4,725 4,725 4,725 4,725 4,725
Reference price 2 2,150 3,193 4,047 5,730 4,761 4,761
Announcement Date 08/05/19 30/04/20 29/04/21 10/04/22 02/03/23 23/04/24
1BDT in Million2BDT
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 3,893 4,126 5,334 4,942 4,969 5,282
EBITDA 1 571.7 942.2 1,164 1,202 1,024 1,246
EBIT 1 500.4 834.3 1,028 1,096 893.1 1,108
Operating Margin 12.85% 20.22% 19.27% 22.17% 17.97% 20.98%
Earnings before Tax (EBT) 1 525.6 879.6 1,078 1,102 892.9 1,101
Net income 1 331.8 619.3 738.9 808.1 659.1 820.5
Net margin 8.52% 15.01% 13.85% 16.35% 13.26% 15.54%
EPS 2 70.22 131.1 156.4 171.0 139.5 173.7
Free Cash Flow 1 449.4 611.5 777.1 498.5 1,098 1,269
FCF margin 11.54% 14.82% 14.57% 10.09% 22.09% 24.03%
FCF Conversion (EBITDA) 78.6% 64.9% 66.74% 41.46% 107.18% 101.89%
FCF Conversion (Net income) 135.44% 98.74% 105.18% 61.68% 166.52% 154.71%
Dividend per Share 2 70.00 125.0 140.0 165.0 98.00 55.00
Announcement Date 08/05/19 30/04/20 29/04/21 10/04/22 02/03/23 23/04/24
1BDT in Million2BDT
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 950 1,312 1,622 1,465 1,791 2,718
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 449 611 777 498 1,098 1,269
ROE (net income / shareholders' equity) 96.3% 117% 99.7% 92.1% 73.9% 80.9%
ROA (Net income/ Total Assets) 18.7% 24.8% 22.8% 21.6% 17.3% 17.6%
Assets 1 1,777 2,492 3,237 3,736 3,815 4,673
Book Value Per Share 2 81.60 143.0 171.0 201.0 177.0 253.0
Cash Flow per Share 2 201.0 284.0 379.0 345.0 419.0 618.0
Capex 1 158 141 370 114 136 167
Capex / Sales 4.05% 3.41% 6.93% 2.31% 2.73% 3.16%
Announcement Date 08/05/19 30/04/20 29/04/21 10/04/22 02/03/23 23/04/24
1BDT in Million2BDT
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
RECKITT BENCKISER (BANGLADESH) PLC Stock Reckitt Benckiser (Bangladesh) PLC
-9.73% 185M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.36% 695B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.40% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.46% 330B
ABBVIE INC. Stock AbbVie Inc.
+3.50% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.34% 239B
NOVARTIS AG Stock Novartis AG
+6.68% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-9.08% 198B
AMGEN INC. Stock Amgen Inc.
+8.62% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. RECKITTBEN Stock
  4. Financials Reckitt Benckiser (Bangladesh) PLC